期刊文献+

临床药师对1例DPN合并高脂血症患者的药学监护 被引量:2

Pharmaceutical Care for a Patient of DPN Complicating with Hyperlipidemia by a Clinical Pharmacist
下载PDF
导出
摘要 目的:探讨对于2型糖尿病合并高脂血症及周围神经病变患者的规范化药学服务方法及模式。方法:临床药师对1例2型糖尿病合并高脂血症及周围神经病变患者用药过程进行全程药学监护。结果:通过全程药学监护,患者血糖控制平稳。结论:临床药师为2型糖尿病合并高脂血症及周围神经病变患者提供全程药学监护,可使患者血糖、血脂控制平稳,不良反应减轻,促进患者用药合理化。 Objective: To explore the methods and patterns of standard pharmaceutical care for the patients with type 2 diabetes mellituscomplicated with hyperlipidemia and peripheral neuropathy. Methods: Clinical pharmacists provided whole-course pharmaceutical care fora inpatient with type 2 diabetes mellitus complicating with hyperlipidemia and peripheral neuropathy. Results: Through the whole process ofpharmaceutical care, patients with stable blood glucose control. Conclusion: The pharmaceutical care provided for patients with type 2 diabetesmellitus complicating with hyperlipidemia and peripheral neuropathy can keep blood lipid stable,reduce ADR and promote rational drug use.
作者 王兆娟 WANG Zhao-juan(Pharmacy department,The people's hospital of Zhangye affiliated to He Xi University,Zhangye Gansu 734000, China)
出处 《药品评价》 CAS 2016年第22期58-60,共3页 Drug Evaluation
关键词 2型糖尿病 周围神经病变 高血脂 药学监护 合理用药 Type 2 Diabetes Mellitus Peripheralneuropathy Hyperlipidemia Pharmaceutical Care Rational Drug use
  • 相关文献

参考文献4

二级参考文献25

  • 1崔丽英.糖尿病周围神经病的研究进展[J].中华神经科杂志,2006,39(7):433-435. 被引量:62
  • 2Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neural, 2012, 11: 521-534.
  • 3Tesfaye S, Boulton A J, Dyck PJ, et al. Diabetic neuropathies : update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care, 2010, 33: 2285-2293.
  • 4Bouhon AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies : a statement by the American Diabetes Association. Diabetes Care, 2005, 28:956-962.
  • 5American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care, 2013, 36 Suppl 1 :$11-66.
  • 6England JD, Gronseth GS, Franklin G, et al. Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve, 2005,31 : 113-123.
  • 7Hilz M J, Datsch M. Quantitative studies of autonomic function. Muscle Nerve, 2006,33 : 6-20.
  • 8England JD, Gronseth GS, Franklin G, et al. PracticeParameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology, 2009,72 : 185-192.
  • 9England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence- based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurolozv. 2009.72 : 177-184.
  • 10Dyck PJ, Windebank AJ. Diabetic and nondiabefic lumbosacral radiculoplexus neuropathies : new insights into pathophysiology and treatment. Muscle Nerve, 2002, 25:477-491.

共引文献6924

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部